Award of the base to emory for ceirr contract 75N93021C00017
Active Definitive Contract Awarded Last action
- Contract number
- 75N93021C00017
- Awardee
-
Emory University UEI S352L5PJLMP8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $29,833,581
Award facts
- Opportunity
-
- NIAID Centers of Excellence for Influenza Research and Response (CEIRR) Pre-Solicitation · 75N93019R00028 · Posted Sep 25, 2019
- NIAID Centers of Excellence for Influenza Research and Response (CEIRR) Award Notice · Posted Mar 26, 2021
- NIAID Centers of Excellence for Influenza Research and Response Solicitation · Posted Oct 30, 2019
- Contract value 38% obligated
-
- $29,833,581.13 Current, with exercised options
- $79,254,599.13 Potential, with all options
- Completion date 75% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Atlanta, GA 30322, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$44,622 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $452,215 | |
| Exercise an Option | $1,119,778 | |
| Exercise an Option | $830,936 | |
| Exercise an Option | $1,246,997 | |
| Exercise an Option | $295,555 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $1,063,811 | |
| Funding Only Action | $2,350,501 | |
| Funding Only Action | $3,173,183 | |
| Exercise an Option | $1,706,283 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $1,046,563 | |
| Exercise an Option | $6,370,062 | |
| Supplemental Agreement for work within scope | $619,715 | |
| Exercise an Option | $452,215 | |
| Exercise an Option | $407,022 | |
| Exercise an Option | $1,033,107 | |
| Exercise an Option | $2,078,345 | |
| Exercise an Option | $1,019,873 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $3,611,371 | |
| Other Administrative Action | $0 | |
| Original award | $1,000,671 |
Show all 30
About this award
The National Institute of Allergy and Infectious Diseases awarded a $79.254 million definitive contract to Emory University for the Centers of Excellence for Influenza Research and Response on April 1, 2021, under a cost-reimbursement, no-fee structure with no set-aside designation.
The contract supports NIAID's multi-disciplinary collaborative network focused on natural history, transmission, pathogenesis, and prevention and control measures for influenza. Place of performance is Atlanta, GA. The period of performance runs through September 23, 2028. The originating solicitation (posted September 25, 2019) anticipated awarding up to seven contracts totaling approximately $20 million per award annually to advance understanding of influenza emergence and transmission in humans and at interspecies interfaces through cohort studies and research response capability.
Emory University, a tax-exempt nonprofit research institution and major recipient of federal biomedical research funding, operates as the prime awardee. Subcontractors include the Regents of The University of Minnesota, the University of Pennsylvania, Penn State University, Georgia State University Research Foundation, the University of Kentucky Research Foundation, the University of Illinois, the University of Wisconsin–Madison, the University of Pittsburgh, South Dakota State University, Auburn University, the Scripps Research Institute, Fundacion Argeninta, Pontificia Universidad Católica De Chile, and the University of Melbourne, among others.
Service Contract Inventory data shows the contract has invoiced $13.625 million across FY2021–FY2025, with FY2025 activity at $4.7 million across 41.8 FTEs and 86,897 contractor hours. Derived government-paid hourly rates ranged from $13.43/hr in FY2021 to $311.90/hr in FY2022 (reflecting the contract ramp-up), stabilizing to $53.89/hr in FY2025. Subcontractors performed 64 percent of total contractor hours in FY2025 across 22 named sub-vendors, indicating deep teaming and distributed research execution across academic and research institutions.
Subawards
Show all 23
Quick answers
Who was awarded contract 75N93021C00017?
75N93021C00017 was awarded to Emory University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 1, 2021.
How much is contract 75N93021C00017 worth?
The government has obligated $29,833,581 on 75N93021C00017. Its potential value, with all options, is $79,254,599.
Was contract 75N93021C00017 competed?
The extent of competition for 75N93021C00017 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award